Published in FASEB J on April 23, 2002
Generation and biological activities of oxidized phospholipids. Antioxid Redox Signal (2010) 2.04
Vanin-1-/- mice exhibit a glutathione-mediated tissue resistance to oxidative stress. Mol Cell Biol (2004) 1.35
Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review. Naunyn Schmiedebergs Arch Pharmacol (2007) 1.35
Heat shock protein 70 regulates cellular redox status by modulating glutathione-related enzyme activities. Cell Stress Chaperones (2007) 1.23
Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice. Am J Pathol (2006) 1.16
CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD. J Am Soc Nephrol (2009) 1.15
Preconditioning with physiological levels of ethanol protect kidney against ischemia/reperfusion injury by modulating oxidative stress. PLoS One (2011) 1.04
Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy? Am J Pathol (2003) 1.02
Vitamin C revisited. Crit Care (2014) 1.01
Sevoflurane ameliorates intestinal ischemia-reperfusion-induced lung injury by inhibiting the synergistic action between mast cell activation and oxidative stress. Mol Med Rep (2015) 0.85
Antioxidant and renoprotective effects of paricalcitol on experimental contrast-induced nephropathy model. Br J Radiol (2012) 0.83
Pharmacological strategies to prevent contrast-induced acute kidney injury. Biomed Res Int (2014) 0.82
Preliminary clinical study of the effect of ascorbic acid on colistin-associated nephrotoxicity. Antimicrob Agents Chemother (2015) 0.81
Profiling of fatty acids released during calcium-induced mitochondrial permeability transition in isolated rabbit kidney cortex mitochondria. Toxicol In Vitro (2011) 0.80
Influence of the selected antioxidants on the stability of the Celsior solution used for perfusion and organ preservation purposes. AAPS PharmSciTech (2009) 0.79
Preventing radiocontrast-induced nephropathy in chronic kidney disease patients undergoing coronary angiography. World J Cardiol (2012) 0.78
Ascorbic acid improves renal microcirculatory oxygenation in a rat model of renal I/R injury. J Transl Int Med (2015) 0.75
New perspectives of volemic resuscitation in polytrauma patients: a review. Burns Trauma (2016) 0.75
Influence of trace elements on stabilization of aqueous solutions of ascorbic acid. Biol Trace Elem Res (2012) 0.75
Comparative study on the protective role of vitamin C and L-arginine in experimental renal ischemia reperfusion in adult rats. Int J Physiol Pathophysiol Pharmacol (2014) 0.75
Effect of N-acetyl cysteine in prevention of contrast nephropathy on patients under intravenous pyelography and contrast CT. Adv Biomed Res (2012) 0.75
Protective Role for Antioxidants in Acute Kidney Disease. Nutrients (2017) 0.75
Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med (2007) 9.44
Correlation between the protein/creatinine ratio in spot urine and 24-hour urine protein. Nefrologia (2012) 1.97
Centrosome overduplication and mitotic instability in PKD2 transgenic lines. Cell Biol Int (2008) 1.89
Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats. J Am Soc Nephrol (2006) 1.79
The shifting pattern of cause-specific mortality in a cohort of human immunodeficiency virus-infected and non-infected injecting drug users. Addiction (2008) 1.58
CD40: an upstream master switch for endothelial cell activation uncovered by RNAi-coupled transcriptional profiling. Blood (2008) 1.56
Prospective assessment of antidonor cellular alloreactivity is a tool for guidance of immunosuppression in kidney transplantation. Kidney Int (2013) 1.54
Early subclinical rejection as a risk factor for late chronic humoral rejection. Transplantation (2012) 1.52
The effects of FK778 in combination with tacrolimus and steroids: a phase II multicenter study in renal transplant patients. Transplantation (2004) 1.44
Low serum mannose-binding lectin as a risk factor for new onset diabetes mellitus after renal transplantation. Transplantation (2009) 1.44
Accuracy and variability of equations to estimate glomerular filtration rates in renal transplant patients receiving sirolimus and/or calcineurin inhibitor immunosuppression. Transpl Int (2008) 1.37
An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document. Nefrologia (2013) 1.37
Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol (2008) 1.15
Impact of hepatitis C infection on long-term mortality of injecting drug users from 1990 to 2002: differences before and after HAART. AIDS (2006) 1.12
Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model. Stem Cells Dev (2012) 1.11
Impact of osteoporosis and vertebral fractures on quality-of-life. a population-based study in Valencia, Spain (The FRAVO Study). Health Qual Life Outcomes (2011) 1.11
Estimation of total glomerular number in stable renal transplants. J Am Soc Nephrol (2003) 1.10
Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates. J Immunol (2007) 1.08
Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients. J Am Soc Nephrol (2008) 1.04
Promising effects of ischemic preconditioning in renal transplantation. Kidney Int (2002) 1.03
Epidemiology, clinical features and outcomes of pneumonia in patients with chronic kidney disease. Nephrol Dial Transplant (2011) 1.02
Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy? Am J Pathol (2003) 1.02
Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies. Kidney Int (2002) 0.99
Malignancy after renal transplantation: the role of immunosuppression. Nat Rev Nephrol (2010) 0.98
Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage? Nephrol Dial Transplant (2009) 0.97
Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation. Transpl Int (2005) 0.97
Regression of advanced diabetic nephropathy by hepatocyte growth factor gene therapy in rats. Diabetes (2004) 0.94
Belatacept: from rational design to clinical application. Transpl Int (2011) 0.93
CD40 gene silencing reduces the progression of experimental lupus nephritis modulating local milieu and systemic mechanisms. PLoS One (2013) 0.93
Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting: lessons learned from first clinical trials. Transplantation (2013) 0.93
Costimulatory blockade with mTor inhibition abrogates effector T-cell responses allowing regulatory T-cell survival in renal transplantation. Transpl Int (2011) 0.92
Development and validation of a population-based prediction scale for osteoporotic fracture in the region of Valencia, Spain: the ESOSVAL-R study. BMC Public Health (2010) 0.91
Treatment of idiopathic membranous nephropathy with the combination of steroids, tacrolimus and mycophenolate mofetil: results of a pilot study. Nephrol Dial Transplant (2007) 0.90
Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats. Nephrol Dial Transplant (2008) 0.90
Renal involvement in non-malignant IgM gammopathy. Nephrol Dial Transplant (2006) 0.89
RNAi-mediated silencing of CD40 prevents leukocyte adhesion on CD154-activated endothelial cells. Blood (2004) 0.89
New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathy. Exp Diabetes Res (2012) 0.89
Overexpression of PKD2 in the mouse is associated with renal tubulopathy. Nephrol Dial Transplant (2007) 0.88
Biomarkers in renal transplantation. Curr Opin Organ Transplant (2010) 0.87
Influence of MRP2 on MPA pharmacokinetics in renal transplant recipients-results of the Pharmacogenomic Substudy within the Symphony Study. Nephrol Dial Transplant (2011) 0.87
Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study). J Nephrol (2004) 0.87
Vertebral fracture risk factors in postmenopausal women over 50 in Valencia, Spain. A population-based cross-sectional study. Bone (2012) 0.87
Baseline immunosuppression is associated with histological findings in early protocol biopsies. Transplantation (2004) 0.86
Do drug transporter (ABCB1) SNPs and P-glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic substudy within the symphony study. Transpl Int (2012) 0.86
Low-dose cyclosporine with mycophenolate mofetil induces similar calcineurin activity and cytokine inhibition as does standard-dose cyclosporine in stable renal allografts. Transplantation (2004) 0.85
TLR4 and NALP3 inflammasome in the development of endothelial dysfunction in uraemia. Eur J Clin Invest (2015) 0.84
Circulating angiotensin-converting enzyme 2 activity in kidney transplantation: a longitudinal pilot study. Nephron Clin Pract (2012) 0.84
Resistive index and chronic allograft nephropathy evaluated in protocol biopsies as predictors of graft outcome. Nephrol Dial Transplant (2005) 0.84
Role of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: a prospective controlled study. PLoS One (2013) 0.83
Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions. Transplantation (2004) 0.83
Mycophenolate mofetil and calcineurin-inhibitor reduction: recent progress. Am J Transplant (2009) 0.83
Optimal immunosuppression to prevent chronic allograft dysfunction. Kidney Int Suppl (2010) 0.83
The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats. Life Sci (2010) 0.83
Reduction of postischemic immune inflammatory response: an effective strategy for attenuating chronic allograft nephropathy. Transplantation (2005) 0.82
Intragraft expression of the IL-10 gene is up-regulated in renal protocol biopsies with early interstitial fibrosis, tubular atrophy, and subclinical rejection. Am J Pathol (2010) 0.82
New options and perspectives for proteinuria management after kidney transplantation. Transplant Rev (Orlando) (2012) 0.82
Kidney regeneration and repair after transplantation. Curr Opin Organ Transplant (2013) 0.82
IgA nephropathy recurs early in the graft when assessed by protocol biopsy. Nephrol Dial Transplant (2011) 0.82
Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function. Transplantation (2005) 0.81
Maize AKINbetagamma dimerizes through the KIS/CBM domain and assembles into SnRK1 complexes. FEBS Lett (2009) 0.81
The renin angiotensin system blockade in kidney transplantation: pros and cons. Transpl Int (2008) 0.81
Reverse dipper pattern of blood pressure at 3 months is associated with inflammation and outcome after renal transplantation. Nephrol Dial Transplant (2011) 0.81
Low-dose sirolimus combined with angiotensin-converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy. Nephrol Dial Transplant (2011) 0.81
Changes in malaria epidemiology in a rural area of Cubal, Angola. Malar J (2015) 0.80
Early hematopoietic microchimerism predicts clinical outcome after kidney transplantation. Transplantation (2007) 0.80
Optimal sparse sampling for estimating ganciclovir/valganciclovir AUC in solid organ transplant patients using NONMEN. Ther Drug Monit (2014) 0.80
Rituximab induces regression of hepatitis C virus-related membranoproliferative glomerulonephritis in a renal allograft. Nephrol Dial Transplant (2006) 0.80
NCAD, a database integrating the intrinsic conformational preferences of non-coded amino acids. J Phys Chem B (2010) 0.80
Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years. Transpl Int (2003) 0.80
Pretransplant interferon prevents hepatitis C virus-associated glomerulonephritis in renal allografts by HCV-RNA clearance. Am J Transplant (2003) 0.80
High phosphate diet increases arterial blood pressure via a parathyroid hormone mediated increase of renin. J Hypertens (2014) 0.79
Induction of suppressive allogeneic regulatory T cells via rabbit antithymocyte polyclonal globulin during homeostatic proliferation in rat kidney transplantation. Transpl Int (2014) 0.79
Control of anti-donor antibody production post-transplantation: conventional and novel immunosuppressive therapies. Contrib Nephrol (2008) 0.79
Side-chain to backbone interactions dictate the conformational preferences of a cyclopentane arginine analogue. J Org Chem (2009) 0.79
Corticosteroid therapy increases HDL-cholesterol concentrations in patients with active sarcoidosis and hypoalphalipoproteinemia. Clin Chim Acta (2002) 0.79